In our study, exogenous IGF-1 (at the dose of 50 μg/kg/d) attenuated tissue injury in mice exposed to the NEC protocol while preserving intestinal endothelial cell proliferation, microvasculature density, and VEGF/VEGFR2 expression. The gene discussed is VEGFA; the disease is necrotizing enterocolitis.